The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways
Open accessAbstract
Exposure to toxic polycyclic aromatic hydrocarbons raises a number of toxic and carcinogenic responses in experimental animals and humans mediated for the most part by the aryl hydrocarbon---or dioxin---receptor (AHR). The AHR is a ligand-activated transcription factor whose central role in the induction of drug-metabolizing enzymes has long been recognized. For quite some time now, it has become clear that the AHR also functions in pathways outside of its role in detoxification and that perturbation of these pathways by xenobiotic ligands may be an important part of the toxicity of these compounds. AHR activation by some of its ligands participates among others in pathways critical to cell cycle regulation, mitogen-activated protein kinase cascades, immediate-early gene induction, cross-talk within the RB/E2F axis and mobilization of crucial calcium stores. Ultimately, the effect of a particular AHR ligand may depend as much on the adaptive interactions that it established with pathways and proteins expressed in a specific cell or tissue as on the toxic responses that it raises.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The JNK signal transduction pathway
Weston, C. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00258-1 · Cited by 1,528
Sibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 1×
“[55] Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, et al.”
BackgroundThe JNK signal transduction pathway
Weston, C. R., & Davis, R. J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.001 · Cited by 1,021
Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., & Dalton, T. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00310-x · Cited by 1,004
Cloning of a Factor Required for Activity of the Ah (Dioxin) Receptor
Hoffman, E. C., Reyes, H., Chu, F.-F., Sander, F., Conley, L. H., Brooks, B. A., & Hankinson, O. (1991) · Science · doi:10.1126/science.1852076 · Cited by 957
Hogenesch, J. B., Chan, W. K., Jackiw, V. H., Brown, R. C., Gu, Y.-Z., Pray-Grant, M., Perdew, G. H., & Bradfield, C. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8581 · Cited by 513
Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis
DeGregori, J., & Johnson, D. (2006) · Current Molecular Medicine · doi:10.2174/1566524010606070739 · Cited by 498
McConkey, D. J., Hartzell, P., Duddy, S. K., Håkansson, H., & Orrenius, S. (1988) · Science · doi:10.1126/science.3262923 · Cited by 450
The aryl hydrocarbon receptor: studies using the AHR-null mice.
Gonzalez, F. J., & Fernández‐Salguero, P. M. (1998) · PubMed · Cited by 448
Ma, Q., & Whitlock, J. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8878 · Cited by 417
Carver, L. A., & Bradfield, C. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11452 · Cited by 416
The aryl hydrocarbon receptor, more than a xenobiotic‐interacting protein
Barouki, R., Coumoul, X., & Fernandez-Salguero, P. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.046 · Cited by 398
Kolluri, S. K., Weiss, C., Koff, A., & Gottlicher, M. (1999) · Genes & Development · doi:10.1101/gad.13.13.1742 · Cited by 364
Checking out the G2/M transition
Smits, V. A. J., & Medema, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00204-4 · Cited by 355
Pratt, W. B. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.297 · Cited by 335
Molecular biology of the Ah receptor and its role in carcinogenesis
Safe, S. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00301-0 · Cited by 332
Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis
Marlowe, J. L., & Puga, A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20656 · Cited by 329
Self-citationPuga, A., Barnes, S. J., Dalton, T. P., Chang, C.-Y., Knudsen, E. S., & Maier, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2943 · Cited by 316
Self-citationMa, Q., & Whitlock, J. P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2144 · Cited by 273
Okey, A. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm096 · Cited by 258
A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein
Ge, N.-L., & Elferink, C. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22708 · Cited by 258
Pollenz, R. S. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00065-0 · Cited by 253
Beischlag, T. V., Wang, S., Rose, D. W., Torchia, J., Reisz-Porszasz, S., Muhammad, K., Nelson, W. E., Probst, M. R., Rosenfeld, M. G., & Hankinson, O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4319-4333.2002 · Cited by 223
Remembrance of things PAS: regulation of development by bHLH–PAS proteins
Crews, S. T., & Fan, C.-M. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00003-9 · Cited by 198
Abbott, B. D., Birnbaum, L. S., & Perdew, G. H. (1995) · Developmental Dynamics · doi:10.1002/aja.1002040204 · Cited by 195
Role of the aryl hydrocarbon receptor in cell cycle regulation
Puga, A., Xia, Y., & Elferink, C. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00069-8 · Cited by 192
Self-citationTan, Z., Chang, X., Puga, A., & Xia, Y. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01138-3 · Cited by 184
Self-citationPUGA, A., NEBERT, D. W., & CARRIER, F. (1992) · DNA and Cell Biology · doi:10.1089/dna.1992.11.269 · Cited by 178
Self-citationOncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors
Currier, N., Solomon, S. E., Demicco, E. G., Chang, D. L. F., Farago, M., Ying, H., Dominguez, I., Sonenshein, G. E., Cardiff, R. D., Xiao, Z.-X. J., et al. (2005) · Toxicologic Pathology · doi:10.1080/01926230500352226 · Cited by 174
Weiß, C., Kolluri, S. K., Kiefer, F., & Göttlicher, M. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0214 · Cited by 170
Long, W. P., Pray-Grant, M., Tsai, J. C., & Perdew, G. H. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.691 · Cited by 167
Altered Cell Cycle Control at the G2/M Phases in Aryl Hydrocarbon Receptor-Null Embryo Fibroblast
Elizondo, G., Fernandez-Salguero, P., Sheikh, M. S., Kim, G.-Y., Fornace, A. J., Lee, K. S., & Gonzalez, F. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26518-4 · Cited by 161
Marlowe, J. L., Knudsen, E. S., Schwemberger, S., & Puga, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404315200 · Cited by 158
Self-citationDimerization in MAP-kinase signaling
COBB, M., & GOLDSMITH, E. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01508-x · Cited by 158
Diry, M., Tomkiewicz, C., Köhle, C., Coumoul, X., Bock, K. W., Barouki, R., & Transy, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209553 · Cited by 157
Protein Kinase C Modulates Regulation of the CYP1A1 Gene by the Aryl Hydrocarbon Receptor
Chen, Y., & Tukey, R. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26261 · Cited by 154
Carrier, F., Owens, R. A., Nebert, D. W., & Puga, A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1856 · Cited by 151
Self-citationReiners, J. J., Lee, J., Clift, R. E., Dudley, D. T., & Myrand, S. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.438 · Cited by 148
Schnekenburger, M., Li, P., & Puga, A. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2007.07.002 · Cited by 141
Self-citationPetrulis, J. R., Kusnadi, A. R., Ramadoss, P., Hollingshead, B. D., & Perdew, G. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209331200 · Cited by 141
The Aryl Hydrocarbon Receptor Binds to E2F1 and Inhibits E2F1-induced Apoptosis
Marlowe, J. L., Fan, Y., Chang, X., Peng, L. H., Knudsen, E. S., Xia, Y., & Puga, A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0359 · Cited by 141
Self-citationHestermann, E. V., & Brown, M. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7920-7925.2003 · Cited by 140
Dioxin Induces Transcription ofandGenes byReceptor-Dependent and -Independent Pathways
Hoffer, A., Chang, C., & Puga, A. (1996) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(96)80029-9 · Cited by 139
Self-citationMaximal Aryl Hydrocarbon Receptor Activity Depends on an Interaction with the Retinoblastoma Protein
Elferink, C. J., Ge, N.-L., & Levine, A. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.664 · Cited by 131
Lecureur, V., Ferrec, E. L., N’Diaye, M., Vée, M. L., Gardyn, C., Gilot, D., & Fardel, O. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.081 · Cited by 127
Mulero‐Navarro, S., Carvajal-González, J. M., Herranz, M., Ballestar, E., Fraga, M. F., Ropero, S., Esteller, M., & Fernández‐Salguero, P. M. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi344 · Cited by 126
Cell Density Regulates Intracellular Localization of Aryl Hydrocarbon Receptor
Ikuta, T., Kobayashi, Y., & Kawajiri, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310492200 · Cited by 125
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis
Schlezinger, J. J., Liu, D., Farago, M., Seldin, D. C., Belguise, K., Sonenshein, G. E., & Sherr, D. H. (2006) · Biological Chemistry · doi:10.1515/bc.2006.145 · Cited by 122
Chang, X., Fan, Y., Karyala, S. V., Schwemberger, S. J., Tomlinson, C. R., Sartor, M. A., & Puga, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00323-07 · Cited by 121
Self-citationBock, K. W., & Köhle, C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.004 · Cited by 119
Viluksela, M., Bager, Y., Tuomisto, J. T., Scheu, G., Unkila, M., Pohjanvirta, R., Flodström, S., Kosma, V., Mäki-Paakkanen, J., Vartiainen, T., et al. (2000) · PubMed · Cited by 117
Wang, S., & Hankinson, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110122200 · Cited by 113
Ikuta, T., Kobayashi, Y., & Kawajiri, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.076 · Cited by 106
Multiple Mechanisms Are Involved in Ah Receptor-Mediated Cell Cycle Arrest
Huang, G., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002410 · Cited by 104
Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment.
Pongratz, I., Strömstedt, P. E., MASON, G. G. F., & Poellinger, L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55374-6 · Cited by 101
Worner, W., & Schrenk, D. (1996) · PubMed · Cited by 99
TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38–MAPK-dependent pathway
Weiß, C., Faust, D., Dürk, H., Kolluri, S. K., Pelzer, A., Schneider, S., Dietrich, C., Oesch, F., & Göttlicher, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208679 · Cited by 96
Barnes, S., Knudsen, K. E., & Puga, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000356 · Cited by 95
Self-citationOkino, S. T., Pendurthi, U. R., & Tukey, R. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50526-9 · Cited by 91
Ogiso, H., Kagi, N., Matsumoto, E., Nishimoto, M., Arai, R., Shirouzu, M., Mimura, J., Fujii-Kuriyama, Y., & Yokoyama, S. (2004) · Biochemistry · doi:10.1021/bi048736m · Cited by 91
Chen, S., Nguyen, N. T., Tamura, K., Karin, M., & Tukey, R. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300780200 · Cited by 90
Perturbation of the Mitosis/Apoptosis Balance: A Fundamental Mechanism in Toxicology,
Roberts, R. A. (1997) · Fundamental and Applied Toxicology · doi:10.1006/faat.1997.2331 · Cited by 87
Andrieux, L. O., Langouët, S., Fautrel, A., Ezan, F., Krauser, J. A., Savouret, J. F., Guengerich, F. P., Baffet, G., & Guillouzo, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.934 · Cited by 85
Role of Mediator in Transcriptional Activation by the Aryl Hydrocarbon Receptor
Wang, S., Ge, K., Roeder, R. G., & Hankinson, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312274200 · Cited by 84
Andrysík, Z., Vondráček, J., Machala, M., Krčmář, P., Sindlerova, L. S., Kranz, A., Weiß, C., Faust, D., Kozubı́k, A., & Dietrich, C. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.10.004 · Cited by 83
Vogel, C. F. A., Li, W., Sciullo, E. M., Newman, J. W. I., Hammock, B. D., Reader, J. R., Tuscano, J. M., & Matsumura, F. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070406 · Cited by 83
TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents
Pääjärvi, G., Viluksela, M., Pohjanvirta, R., Stenius, U., & Högberg, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh289 · Cited by 81
TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A
Weiss, C., Faust, D., Schreck, I., Ruff, A., Farwerck, T., Melenberg, A., Schneider, S., Oesch‐Bartlomowicz, B., Zatloukalová, J., Vondráček, J., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210859 · Cited by 80
Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest
Strobeck, M. W., Fribourg, A. F., Puga, A., & Knudsen, E. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203510 · Cited by 78
Self-citationRole of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein
Chan, H. M., Smith, L. M., & Thangue, N. B. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204793 · Cited by 76
Dvořák, Z., Vrzal, R., Henklová, P., Jančová, P., Anzenbacherová, E., Maurel, P., Svecova, L., Pávek, P., Ehrmann, J., Havlík, R., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.013 · Cited by 76
A Critical Role For MAP Kinases in the Control of Ah Receptor Complex Activity
Tan, Z., Huang, M., Puga, A., & Xia, Y. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh228 · Cited by 76
Self-citationAh receptor ligands and tumor promotion: survival of neoplastic cells
Schwarz, M., Buchmann, A., Stinchcombe, S., Kalkuhl, A., & Bock, K. W. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00247-7 · Cited by 71
Role of mitogen-activated protein kinases in aryl hydrocarbon receptor signaling
Henklová, P., Vrzal, R., Ulrichová, J., & Dvořák, Z. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.12.005 · Cited by 67
Mahon, M. J., & Gasiewicz, T. A. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1217 · Cited by 61
ERK Kinase Inhibition Stabilizes the Aryl Hydrocarbon Receptor
Chen, S., Operaña, T. N., Bonzo, J. A., Nguyen, N. T., & Tukey, R. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411554200 · Cited by 58
Environmental toxicant-induced germ cell apoptosis in the human fetal testis
Coutts, S. M., Fulton, N., & Anderson, R. A. (2007) · Human Reproduction · doi:10.1093/humrep/dem300 · Cited by 58
Wu, R., Zhang, L., Hoagland, M. S., & Swanson, H. I. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111773 · Cited by 57
Gierthy, J. F., & Crane, D. D. (1984) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(84)90274-6 · Cited by 54
Aryl Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by Adenovirus E1A
Tohkin, M., Fukuhara, M., Elizondo, G., Tomita, S., & Gonzalez, F. J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.845 · Cited by 53
Caruso, J. A., Mathieu, P., Joiakim, A., Zhang, H., & Reiners, J. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508383200 · Cited by 53
Park, S.-K., Henry, E. C., & Gasiewicz, T. A. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1999 · Cited by 52
Joiakim, A., Mathieu, P., Palermo, C. M., Gasiewicz, T. A., & Reiners, J. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1279 · Cited by 48
Park, S., Yoon, W., Kim, H., et al. (2005) · PubMed · Cited by 48
Bauman, J. W., Goldsworthy, T. L., Dunn, C. S., & Fox, T. R. (1995) · Cell Proliferation · doi:10.1111/j.1365-2184.1995.tb00084.x · Cited by 45
2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes
Hushka, D. R., & Greenlee, W. F. (1995) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00135-2 · Cited by 45
Sarioglu, H., Brandner, S., Haberger, M., Jacobsen, C., Lichtmannegger, J., Wormke, M., & Andrae, U. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700258-mcp200 · Cited by 44
Minsavage, G. D., Park, S.-K., & Gasiewicz, T. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312977200 · Cited by 37
Li, S.-Y., & Dougherty, J. J. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9905 · Cited by 35
Peng, L. H., Mayhew, C. N., Schnekenburger, M., Knudsen, E. S., & Puga, A. (2008) · Toxicology · doi:10.1016/j.tox.2008.01.002 · Cited by 30
Self-citationInhibition of the MEK-1/p42 MAP kinase reduces aryl hydrocarbon receptor–DNA interactions
Yim, S., Oh, M., Choi, S., & Park, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.072 · Cited by 28
Dieter, M. Z., Freshwater, S. L., Solis, W. A., Nebert, D. W., & Dalton, T. P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00525-6 · Cited by 21
Ikegwuonu, F. I., Christou, M., & Jefcoate, C. R. E. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00344-x · Cited by 18
Shibazaki, M., TAKEUCHI, T., Ahmed, S., & KIKUCHIA, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.034 · Cited by 16
Dieter, M. Z., Freshwater, S. L., Solis, W. A., Nebert, D. W., & Dalton, T. P. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01230-3 · Cited by 9
Cited by
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
A review on endocrine disruptors and their possible impacts on human health
Kabir, E. R., Rahman, M. S., & Rahman, I. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.06.009 · Cited by 945
Interleukin-22: Immunobiology and Pathology
Dudakov, J. A., Hanash, A. M., & van den Brink, M. R. M. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112123 · Cited by 905
Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748
Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action
De Coster, S., & van Larebeke, N. (2012) · Journal of Environmental and Public Health · doi:10.1155/2012/713696 · Cited by 617
Metadata
- Authors
- Puga, A., Ma, C., & Marlowe, J. L.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 77
- Issue
- 4
- Pages
- 713-722
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2093853598
- Cited by
- 410
- References
- 97
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.